Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes

Area of Science:

• Hematology
• Cell Biology
• Molecular Pharmacology

Background:

• Adenosine diphosphate (ADP) interaction with P2Y(1) and P2Y(12) receptors is crucial for platelet function.
• The role of ADP and its receptors in human megakaryocytes remains largely unknown.

Purpose of the Study:

• To investigate the function of ADP and P2Y receptors in human megakaryocyte proplatelet formation.
• To elucidate the specific P2Y receptor subtype involved in ADP-mediated regulation of megakaryopoiesis.

Main Methods:

• Studied proplatelet formation in human megakaryocytes in culture.
• Utilized ADP scavengers, P2Y(1) and P2Y(12) inhibitors, and a specific P2Y(13) inhibitor (MRS 2211).
• Examined megakaryocytes from a patient with congenital P2Y(12) deficiency and patients with delta-storage pool deficiency.

Main Results:

• Megakaryocytes express all eight P2Y receptor subtypes and release ADP.
• Proplatelet formation was inhibited by ADP scavengers and P2Y(12)/P2Y(13) inhibitors, but not by a P2Y(1) inhibitor.
• Specific P2Y(13) inhibition significantly reduced proplatelet formation, suggesting P2Y(13) is the key receptor.
• Megakaryocytes from P2Y(12)-deficient patients showed normal proplatelet formation, further implicating P2Y(13).
• Patients lacking secretable ADP had significantly lower platelet counts, confirming ADP's role in platelet production.

Conclusions:

• Demonstrated that ADP released by megakaryocytes regulates their function via P2Y(13) receptors.
• Identified a novel physiological role for ADP and P2Y(13) in megakaryocyte proplatelet formation.
• The clinical relevance of this ADP-P2Y(13) axis in platelet production warrants further investigation.